Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats (2024)
- Authors:
- USP affiliated authors: COTRIM, PAULO CESAR - FM ; BARBOSA JUNIOR, FERNANDO - FCFRP ; ROCHA, BRUNO ALVES - FCFRP ; CORREIA, CRISTIANO DE JESUS - FM ; ARAUJO, GABRIEL LIMA BARROS DE - FCF ; CHACRA, NÁDIA ARACI BOU - FCF ; FALOPPA, ANA CRISTINA BREITHAUPT - FM
- Unidades: FM; FCFRP; FCF
- DOI: 10.2217/nnm-2023-0263
- Subjects: LEISHMANIA; SISTEMA LINFÁTICO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Nanomedicine
- ISSN: 1743-5889
- Volume/Número/Paginação/Ano: v. 19, n. 4, p. 293-301, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 13 fev. 2026. -
APA
Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263 -
NLM
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2026 fev. 13 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263 -
Vancouver
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2026 fev. 13 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263 - Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases
- Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment
- Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats
- Processo de obtenção de carreadores lipídicos nanoestruturados, carreadores lipídicos nanoestruturados obtidos e uso dos mesmos
- Sistema nanoestruturado polimérico e seu uso
- Rapid, sensitive and simultaneous determination of 16 endocrine-disrupting chemicals (parabens, benzophenones, bisphenols, and triclocarban) in human urine based on microextraction by packed sorbent combined with liquid chromatography tandem mass spectrometry (MEPS-LC-MS/MS)
- Arsenic in mining areas: environmental contamination routes
- Evidence on neurotoxicity after intrauterine and childhood exposure to organomercurials
- Processo de obtenção de formulações nanocristalinas de flubendazol, formulações nanocristalinas de flubendazol e uso
- Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
Informações sobre o DOI: 10.2217/nnm-2023-0263 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
